Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-26 · accession 0001055726-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-28 | 2023-02-27 | INO | Weiner David B. | Dir | S - Sale+OE | $1.28 | -11.7K | 904.3K | -1% | -$14.9K |
| DM | 2023-02-28 | 2023-02-26 | INO | Weiner David B. | Dir | M - OptEx | — | +23.3K | 904.3K | +3% | — |
| DM | 2023-02-28 | 2023-02-26 | INO | Weiner David B. | Dir | M - OptEx | $0.00 | -23.3K | 11.7K | -67% | $0 |
| DM | 2023-02-28 | 2023-02-27 | INO | Weiner David B. | Dir | A - Grant | $0.00 | +95.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 11,668 | $1.28 | 904,291 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-26 | M | A | 11,667 | — | 915,959 | D | — | — | (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Common | Common Stock | 2023-02-26 | M | A | 11,667 | — | 904,292 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 11,667 | $0.00 | 23,333 | D | — · — to — | 11,667 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 5 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 11,667 | $0.00 | 11,666 | D | — · — to — | 11,667 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Restricted Stock Unit | 2023-02-27 | A | A | 35,000 | $0.00 | 35,000 | D | — · — to — | 35,000 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 7 | Derivative | Common Stock Option | 2023-02-27 | A | A | 60,000 | $0.00 | 60,000 | D | $1.24 · 2023-02-27 to 2033-02-27 | 60,000 Common Stock | (F4) The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026. |